Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Marker Therapeutics Inc (MRKR)
Marker Therapeutics Inc (MRKR) News

MRKR

Marker Therapeutics (MRKR)

Marker Therapeutics Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MRKR

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
03/18/2022	5:23PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:MRKR	Marker Therapeutics Inc
03/18/2022	6:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
03/17/2022	5:45PM	GlobeNewswire Inc.	Marker Therapeutics Reports Fiscal Year 2021 Operating and Financial Results	NASDAQ:MRKR	Marker Therapeutics Inc
03/07/2022	4:05PM	GlobeNewswire Inc.	Marker Therapeutics to Present at Two Upcoming March Investor Conferences	NASDAQ:MRKR	Marker Therapeutics Inc
02/22/2022	5:15PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
02/22/2022	5:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
02/22/2022	5:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
02/22/2022	5:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
02/22/2022	5:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
02/22/2022	5:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
02/22/2022	5:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
02/18/2022	4:06PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
02/16/2022	4:33PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
02/16/2022	4:30PM	GlobeNewswire Inc.	Marker Therapeutics Announces Clinical Program Updates and Pipeline Expansion	NASDAQ:MRKR	Marker Therapeutics Inc
02/08/2022	4:05PM	GlobeNewswire Inc.	Marker Therapeutics to Host Clinical Program Update Conference Call and Webcast on Wednesday, February 16, 2022	NASDAQ:MRKR	Marker Therapeutics Inc
01/20/2022	6:51AM	Dow Jones News	Marker Therapeutics Shares Rise Premarket on Key FDA Designation	NASDAQ:MRKR	Marker Therapeutics Inc
01/20/2022	6:00AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
01/19/2022	4:49PM	GlobeNewswire Inc.	Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Pancreatic Cancer	NASDAQ:MRKR	Marker Therapeutics Inc
12/09/2021	5:19PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MRKR	Marker Therapeutics Inc
12/09/2021	8:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
12/09/2021	7:00AM	PR Newswire (US)	Marker Therapeutics Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors	NASDAQ:MRKR	Marker Therapeutics Inc
11/18/2021	4:05PM	PR Newswire (US)	Marker Therapeutics Announces that Data from Investigator-Sponsored Phase 1 Study With its MultiTAA-Specific T Cells to be Presented at the 2021 American Society of Hematology Annual Meeting	NASDAQ:MRKR	Marker Therapeutics Inc
11/15/2021	7:11AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
11/10/2021	4:11PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MRKR	Marker Therapeutics Inc
11/10/2021	4:05PM	PR Newswire (US)	Marker Therapeutics Reports Third Quarter 2021 Operating and Financial Results	NASDAQ:MRKR	Marker Therapeutics Inc
09/07/2021	4:05PM	PR Newswire (US)	Marker Therapeutics to Present at Three Upcoming September Investor Conferences	NASDAQ:MRKR	Marker Therapeutics Inc
08/20/2021	6:03AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:MRKR	Marker Therapeutics Inc
08/19/2021	4:13PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
08/19/2021	4:05PM	PR Newswire (US)	Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas	NASDAQ:MRKR	Marker Therapeutics Inc
08/10/2021	5:11PM	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:MRKR	Marker Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:MRKR

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Canopus Biopharma (PK)

Gold and GemStone Mining (PK)

Marketing Worldwide (PK)

Virexit Technologies (PK)

Bell Buckle (PK)

Ubiquitech Software (PK)

Brookmount Explorations (PK)

NioCorp Developments

Fannie Mae (QB)

Anavex Life Sciences

Seven Arts Entertainment (PK)

Decentral Life (PK)

Delayed Upgrade Clock